Abstract
Nonventilator hospital-acquired pneumonia is associated with substantial morbidity, mortality, and costs during an episode of acute care. We examined NVHAP incidence, mortality, and costs of Medicaid beneficiaries over a 5-year period (2015-2019). Overall NVHAP incidence was 2.63 per 1,000 patient days, and mortality was 7.76%, with an excess cost per NVHAP case of $20,189.
| Original language | English |
|---|---|
| Pages (from-to) | 227-230 |
| Number of pages | 4 |
| Journal | American Journal of Infection Control |
| Volume | 51 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2023 |
Keywords
- Epidemiology
- NVHAP
- Non-ventilator Hospital-acquired pneumonia
- Nosocomial infection
Fingerprint
Dive into the research topics of 'Incidence, mortality, and cost trends in nonventilator hospital-acquired pneumonia in medicaid beneficiaries, 2015-2019'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver